Patent details

EP3093025 Title: BLUETONGUE VIRUS RECOMBINANT VACCINES AND USES THEREOF

Basic Information

Publication number:
EP3093025
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161711130
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BLUETONGUE VIRUS RECOMBINANT VACCINES AND USES THEREOF
French Title of Invention:
VACCINS DE RECOMBINAISON DU VIRUS DE LA FIEVRE CATARRHALE ET UTILISATIONS DE CEUX-CI
German Title of Invention:
REKOMBINANTE BLAUZUNGEN-IMPFSTOFFE UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
11/03/2011
Grant date:
01/08/2018
EP Publication Date:
16/11/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/08/2018
EP B1 Publication Date:
01/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/03/2019
Expiration date:
11/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/07/2018
 
 

Name:
Merial Inc.
Address:
3239 Satellite Boulevard, Bldg. 500, Duluth, GA 30096, United States (US)

Inventor

1

Name:
COX, Kevin
Address:
United States (US)

2

Name:
AUDONNET, Jean-Christophe
Address:
France (FR)

3

Name:
GUO, Xuan
Address:
United States (US)

Priority

1

Priority Number:
313164 P
Priority Date:
12/03/2010
Priority Country:
United States (US)

2

Priority Number:
366363 P
Priority Date:
21/07/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/135; C12N 15/82;

Publication

European Patent Bulletin

Issue number:
201831
Publication date:
01/08/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages